FOMX

Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX

Overview Fund Activity
Delisted

FOMX was delisted on the 6th of March, 2020.

Back to rankings

56 hedge funds and large institutions have $102M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 18 closing their positions.

Holders
56
Holders Change
-11
Holders Change %
-16.42%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
8
Increased
20
Reduced
13
Closed
18
Calls
$9K
Puts
$206K
Net Calls
-$197K
Net Calls Change
-$3.62M

Top Buyers

1
GPP
1
Great Point Partners
Connecticut
$22.2M
2
OM
2
Opaleye Management
Massachusetts
$5.27M
3
MWNA
3
Marshall Wace North America
New York
$3.16M
4
IBT
4
International Biotechnology Trust
United Kingdom
$1.67M
5
Bank of New York Mellon
5
Bank of New York Mellon
New York
$2.53M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
O
2
OppenheimerFunds
New York
$0
3
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$955K
4
SFM
4
Sphera Funds Management
Israel
$0
5
EU
5
Emory University
Georgia
$0
Name Market Value Shares Shares
Change 		Shares
Change %
GPP
1
Great Point Partners
Connecticut
$22.2M 4,781,708 +1,100,000 +30%
BBA
2
Baker Bros. Advisors
New York
$11.4M 2,466,702 – –
Franklin Resources
3
Franklin Resources
California
$6.96M 1,499,370 +500 +0%
DA
4
DSC Advisors
Illinois
$5.51M 1,186,654 – –
OM
5
Opaleye Management
Massachusetts
$5.27M 1,135,000 +635,000 +127%
PA
6
Perceptive Advisors
New York
$5.18M 1,117,324 -205,670 -16%
Axa
7
Axa
France
$4.37M 942,735 +116,298 +14%
TCM
8
Tekla Capital Management
Massachusetts
$4.32M 930,398 – –
VC
9
Vivo Capital
California
$3.97M 855,000 – –
DM
10
Deerfield Management
New York
$3.79M 817,435 – –
MWNA
11
Marshall Wace North America
New York
$3.16M 632,819 +189,350 +43%
SAM
12
Senzar Asset Management
New York
$2.64M 569,197 -5,600 -1%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$2.53M 544,853 +151,849 +39%
BlackRock
14
BlackRock
New York
$2.48M 535,403 +19,258 +4%
DCM
15
Driehaus Capital Management
Illinois
$2.36M 509,535 +77,137 +18%
FHAM
16
Folger Hill Asset Management
New York
$2.1M 451,869 – –
IBT
17
International Biotechnology Trust
United Kingdom
$1.67M 358,975 +161,137 +81%
DCM
18
DAFNA Capital Management
California
$1.65M 355,667 +30,000 +9%
Jennison Associates
19
Jennison Associates
New York
$1.54M 331,658 -8,631 -3%
Baillie Gifford & Co
20
Baillie Gifford & Co
United Kingdom
$1.02M 219,400 – –
Alyeska Investment Group
21
Alyeska Investment Group
Illinois
$955K 205,870 -296,709 -59%
CM
22
Crestline Management
Texas
$824K 177,488 +75,788 +75%
Renaissance Technologies
23
Renaissance Technologies
New York
$719K 154,900 +92,886 +150%
SCM
24
Sio Capital Management
New York
$646K 139,200 +139,200 New
Goldman Sachs
25
Goldman Sachs
New York
$586K 126,280 -22,701 -15%
1
2 3